Web-based collaboration and advanced-analytic simulation improve R&D portfolio management, optimize strategic and long-range planning, and set the stage for “evergreen” portfolio management.
Drug developers make huge investments
Drug developers make huge investments, some with 10-year development timelines, or more.
Extreme technical and regulatory uncertainty
They face extreme technical and regulatory uncertainty about these investments.
Must cross-manage a vast portfolio of potential products
Meanwhile, they must cross-manage a vast portfolio of potential products at varying stages of development.
Analyze a range of potential outcomes
The company wanted the ability to analyze a range of potential outcomes in two separate areas:
Line items on the Profit and Loss (P&L) statement
Expected R&D spending (taking timeline uncertainty into account)
Vanguard delivered a system that lets the company test different courses of action and perform sensitivity analyses to quantify the effects of drivers on outcomes.
Impact on client’s business
75% drop in labor hours.
Improved R&D cost management.
More effective portfolio risk management.
Much more easily test different courses of action
The system that Vanguard Software delivered has indeed enabled the company’s R&D Portfolio Managers to much more easily test different courses of action.
Managers can get an automated roll-up of projects into a multi-year
Managers can get an automated roll-up of projects into a multi-year, companywide projection of future operational and financial performance.
Vanguard integrates well with the company’s other critical systems
Vanguard integrates well with the company’s other critical systems and provides a flexible platform that will support future enhancements.
“We chose Vanguard Predictive Planning primarily because it was one of the few systems that could handle the complexity of data, simulation, and analysis that we required. We also appreciated the capability of the development team.” — Company Portfolio Manager.